| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000015804 |
| Receipt No. | R000018390 |
| Official scientific title of the study | Deep venous thrombosis after total knee joint arthroplasty in hemophilia |
| Date of disclosure of the study information | 2014/12/01 |
| Last modified on | 2016/06/01 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Deep venous thrombosis after total knee joint arthroplasty in hemophilia | |
| Title of the study (Brief title) | DVT after TKA in haemophilia | |
| Region |
|
|
| Condition | |||
| Condition | haemophilia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | evaluation of deep venous thrombosis risk after total knee arthroplasty in coagulation deisease such as haemophilia |
| Basic objectives2 | Others |
| Basic objectives -Others | relationship with goagulation examination and deep venous thrombosis |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | evaluation of deep venous thrombisis before and after total knee arthroplasty |
| Key secondary outcomes | compairment between the coagulation blood examination and the risk of deep venous thrombosis |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | on tourniquet during operation | |
| Interventions/Control_2 | off tourniquet during operation | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | indication of total knee arthroplasty
|
|||
| Key exclusion criteria | inhibitor | |||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | takedani hidyeuki |
| Organization | research hosipital of institute of medical science |
| Division name | Joint surgery |
| Address | sirokanedai 4-6-1 Minatoku Tokyo |
| TEL | 03-3443-8111 |
| takedani@ims.u-tokyo.ac.jp | |
| Public contact | |
| Name of contact person | takedani hidyeuki |
| Organization | research hosipital of institute of medical science |
| Division name | Joint surgery |
| Address | sirokanedai 4-6-1 Minatoku Tokyo |
| TEL | 03-3443-8111 |
| Homepage URL | |
| takedani@ims.u-tokyo.ac.jp | |
| Sponsor | |
| Institute | takedani hidyeuki |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | research hosipital of institute of medical science |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018390 |